These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2962072)

  • 21. Clinical aspects of inhaled anticholinergic therapy.
    Campbell SC
    Respir Care; 2000 Jul; 45(7):864-7. PubMed ID: 10926384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological prevention of exercise-induced bronchospasm: review of the literature and trial of disodium cromoglycate, fenoterol and ipratropium bromide in a pediatric population].
    Verini M; Chiarelli F; Di Tullio A; Morgese G; Pallotta R
    Pediatr Med Chir; 1983; 5(6):501-9. PubMed ID: 6152334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxitropium bromide, a new anticholinergic bronchodilator.
    Skorodin MS; Gross NJ; Moritz T; King FW; Armstrong W; Wells D; Galavan E; Slutsky L
    Ann Allergy; 1986 Mar; 56(3):229-32. PubMed ID: 3513670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.
    Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L
    Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Kaik G; Kaik B; Laggner A
    Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Milestones in inhalation therapy of airway diseases].
    Wettengel R
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():7-11. PubMed ID: 12593175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats.
    Leemans J; Kirschvink N; Bernaerts F; Clercx C; Cambier C; Gustin P
    Vet J; 2009 May; 180(2):236-45. PubMed ID: 18294877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bronchodilator effects of an atropinic compound: oxitropium pressurized aerosol. Comparison with theophylline in asthma].
    Gayrard P; Orehek J
    Rev Pneumol Clin; 1984; 40(4):273-4. PubMed ID: 6545469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of protection by oxitropium bromide against cholinergic challenge.
    Wilson NM; Green S; Coe C; Barnes PJ
    Eur J Respir Dis; 1987 Nov; 71(5):455-8. PubMed ID: 3327703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticholinergic therapy in chronic asthma.
    Sterling GM
    Postgrad Med J; 1987; 63 Suppl 1():41-6. PubMed ID: 2962073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D; Kercsmar CM; Myers TR; O'riordan MA; Golonka G; Moore S
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.
    Rafferty P; Beasley R; Holgate ST
    Thorax; 1988 Jun; 43(6):446-50. PubMed ID: 2971274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma.
    Nakano Y; Enomoto N; Kawamoto A; Hirai R; Chida K
    J Allergy Clin Immunol; 2000 Sep; 106(3):472-8. PubMed ID: 10984366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the anticholinergic agent oxitropium bromide in elderly patients with bronchial asthma.
    Shioya T; Kagaya M; Onodera A; Miura S; Shindo T; Sano M; Sasaki M; Miura M
    Arzneimittelforschung; 1996 Dec; 46(12):1130-3. PubMed ID: 9006786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.
    Clarke PS; Jarrett RG; Hall GJ
    Ann Allergy; 1982 Mar; 48(3):180-3. PubMed ID: 6461281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of muscarinic receptor blockers on non-specific bronchial reactivity in patients with bronchial asthma].
    Siergiejko Z
    Pneumonol Alergol Pol; 1992; 60(11-12):32-6. PubMed ID: 1303776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of nocturnal asthma by an inhaled anticholinergic drug.
    Coe CI; Barnes PJ
    Chest; 1986 Oct; 90(4):485-8. PubMed ID: 3530643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of exercise-induced asthma by oxitropium bromide.
    Taytard A; Vergeret J; Guenard H; Vaida P; Bellvert P; Freour P
    Eur J Clin Pharmacol; 1987; 33(5):455-8. PubMed ID: 3428339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.